论文部分内容阅读
Infectious diseases caused by microbes are a serious public safety issues associated with significant mortality and health-care costs in world-wide.Hence,the development of alternative novel drugs is essential with more potent “resistance-resistant” antimicrobial agents that would lead new modes of action and a broad spectrum of activities.